Stories

Corporate

Mar 17, 2022
An Interview with our Novartis Ireland Country President
Corporate
Corporate

Mar 17, 2022
Making Possible: Stepping toward a future with cell and gene therapy
Corporate
Corporate

Mar 17, 2022
Novartis utilizing manufacturing capacity to help in the fight against COVID-19
Corporate
Corporate

Mar 17, 2022
Reimagining Science in #InnovateForLife Campaign
Corporate
Corporate

Mar 17, 2022
Novartis Announces Winners of the Innovation Prize for Assistive Tech
Corporate
Corporate

Mar 17, 2022
Novartis Ireland is supporting #HoldFirm
Corporate
Corporate

Mar 17, 2022
A visual tour of scientific strategies for combating coronavirus
Corporate
Corporate

Mar 17, 2022
Novartis Ireland providing a broad range of initiatives to respond to communities impacted by COVID-19
Corporate
Corporate

Mar 17, 2022
Novartis Partnership with Trinity Centre for People with Intellectual Disabilities
Corporate
Corporate

Mar 17, 2022
Novartis opens facility for innovative cell and gene therapies in Switzerland
Corporate
Corporate

Mar 17, 2022
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Corporate
Corporate

Mar 17, 2022
Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor
Corporate